We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Diagnostic Accuracy Compared for Biomarkers of Acute Heart Failure

By LabMedica International staff writers
Posted on 25 Jan 2017
Print article
Image: The AxSYM automated immunoassay diagnostic analyzer system (Photo courtesy of Abbott Laboratories).
Image: The AxSYM automated immunoassay diagnostic analyzer system (Photo courtesy of Abbott Laboratories).
Candidate biomarkers in cardiac disease include the proteins galectin-3, soluble ST2 (sST2) and B-type natriuretic peptide (BNP), but their prognostic value in acute heart failure is uncertain.

In the pathophysiology of cardiac disease, galectin-3 is thought to play a role through inflammation and fibrosis while blood concentrations of sST2 are significantly increased, in for example inflammatory/infectious diseases, in cancer and in cardiac disease.

Scientists at the Konventhospital Barmherzige Brueder and their colleagues compare head-to-head the diagnostic and prognostic capabilities of galectin-3, soluble ST2 (sST2) and B-type natriuretic peptide (BNP) for heart failure (HF) in an emergency setting. They studied 251 consecutive patients with dyspnea as a chief compliant presenting to an emergency department. The diagnosis of heart failure (HF) was based on the Framingham score for HF plus echocardiographic evidence of systolic or diastolic dysfunction. All-cause mortality was assessed at one year.

The team collected blood samples for the measurement of BNP concentrations, which were analyzed within the next four hours by a commercially available microparticle enzyme immunoassay assay on an AxSYM analyzer. They measured galectin-3 concentrations with a chemiluminescent microparticle immunoassay on an Abbott’s ARCHITECT i2000SR analyzer and sST2 concentrations with the Presage ST2 enzyme-linked immunosorbent assay on a BEP 2000 instrument.

Of the 251 patients, 137 had dyspnea attributable to acute HF and 114 had dyspnea attributable to other reasons. Of the 137 patients with acute HF, 41 died and 96 survived during follow up. BNP had a higher area under the curve (AUC) for the diagnosis of HF than galectin-3 and sST2. Cut-off values with the highest diagnostic accuracies were 295 ng/L for BNP (sensitivity, 80%; specificity, 86%), 25.9 ng/mL for galectin-3 (sensitivity, 41%; specificity, 75%) and 26.5 ng/mL for sST2 (sensitivity, 76%; specificity, 49%). In contrast to BNP, the biomarkers galectin-3 and sST2 were not independently associated with the diagnosis of acute HF.

The authors concluded that galectin-3, sST2 and BNP were equally useful for the prediction of one-year all-cause mortality in patients with acute HF. However, in contrast to BNP, galectin-3 and sST2 were not useful as an aid in the diagnosis of acute HF in short of breath patients presenting to an emergency department. The study was published on December 1, 2016, in the journal Clinica Chimica Acta.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.